Many marketers don’t take advantage of competitor audits, so we have to ask: When was the…
Author: admin
How to Write an Effective Email: 14 Pro Email Writing Tips
Writing compelling emails is a superpower that most professionals would love to have. Email is the…
Autoimmune Drugs Market size to grow by USD 29,314.5 million between 2022 and 2027; AbbVie Inc., and AdvaCare Pharma among others, identified as key vendors – Technavio
The autoimmune drugs market size is set to grow by USD 29314.5 million between 2022 and 2027 and register a…
Global Cellulite Treatment Global Market 2023-2030: Increasing Trend of Anti-Cellulite Massage Presents Opportunities
The “Global Cellulite Treatment Market 2023-2030” report has been added to ResearchAndMarkets.com’s offering. This research report predicts that the global…
Global Home Healthcare Market Report 2023: Increasing use of Telehealth Drives Growth
The “Home Healthcare Market: Global Market Size, Forecast, Insights, Segmentation, and Competitive Landscape with Impact of COVID-19…
TVM Capital Healthcare opens office in Riyadh, Saudi Arabia
TVM Capital Healthcare, a global specialist healthcare private equity firm operating in emerging markets, announced today…
Rona Therapeutics and Keymed Biosciences Announce Collaboration to Discover and Develop First-in-class siRNA Therapeutics for Glomerulonephritis
Rona Therapeutics, Inc (“Rona”) and Keymed Biosciences (“Keymed”, HKEX: 02162), today announced a collaboration to jointly…
Global Liquid Handling System Market Report 2023: Rising Market Demand for High-Throughput Screening Bolsters Growth
The “Global Liquid Handling System Market by Product (Pipette, Consumables, Liquid Handling Workstations, Burettes, Software), Type (Automated,…
Cryogenic Vials Market size to grow by USD 66.16 million from 2022 to 2027, North America to account for 36% of the market growth – TechnavioHealth Care & Hospitals
The latest report on the cryogenic vials market, 2023-2027 estimates to register an incremental growth of USD 66.16 million, almost at…
Shorla Oncology & EVERSANA Announce Commercial Launch of Recent FDA-Approved Nelarabine Injection for the Treatment of T-cell Leukemia Across the United States
Shorla Oncology (‘Shorla’), a U.S.-Irelandpharmaceutical company, and EVERSANA®, a leading provider of commercialization services to the life science…